Patent · US Active

Nanoparticle derivatives of gemcitabine

US8044034B2 · kind B2 · utility

1Cited by

2References

14Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITÉ PARIS-SUD · DE

Inventors

Patrick Couvreur · Palaiseau, FR
Barbara Stella · Torino, IT
Luigi Cattel · Pecetto, IT
Flavio Rocco · Nichelino, IT
Jack-Michel Renoir · L'Haÿ-les-Roses, FR
Véronique Rosilio · Paris, FR

Key dates

Filing date	Mar 4, 2010
Grant date	Oct 25, 2011
Priority date	—
Expiry date	Mar 4, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of squalenic acid or a derivative thereof in formulating at least one polar active principle with a molecular weight of 100 Da or more, in the form of nanoparticles, and pharmaceutical compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.